在病细胞模型中,PTEN-L除了帕金和Ub Ser65,以加剧线粒功能障碍
Xueyuan Li1, Jie Li1, Fengting Gou1
1Sanya Institute of China Agriculture University, China Agricultural University, Sanya 572024, China; National Key Laboratory of Veterinary Public Health and Safety, National Animal Transmissible Spongiform Encephalopathy Laboratory, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
阳性疾病通过增加PTEN-L来损害线粒细胞衰变,这会使帕金和乌比奎丁脱,从而阻碍受损线粒体的清除. 准PTEN-L可能为普病提供一种新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 线粒体功能障碍,特别是PINK1-帕金因依赖性通路,有助于 prion 疾病中的线粒体损伤.
- 精确的分子机制驱动病中线粒衰弱的精确分子机制尚未完全理解.
- 帕金在Ser65 (pSer65-Parkin) 的酸化对于启动PINK1-帕金介导的线粒至关重要.
研究的目的:
- 阐明PTEN-L在调节质病中线粒体功能障碍中的作用.
- 研究PTEN-L影响帕金酸化和线粒细胞衰变的分子机制.
- 评估PTEN-L作为潜在的治疗病的治疗标.
主要方法:
- 使用的病细胞模型 (使用PrP106-126治疗的SH-SY5Y细胞).
- 评估了PTEN-L表达,线粒体转位,以及其对帕金和无处不在素的酸酶活性.
- 研究了PTEN-L调制 (过度表达和淘汰) 对线粒细胞衰变标记物和神经元亡的影响.
主要成果:
- PrP106-126治疗增加了PTEN-L表达和线粒体局部化,导致减少了pser65-Parkin和pser65-Ub.
- 过度表达PTEN-L模仿了PrP106-126的效果,而PTEN-L敲击恢复了线粒细胞衰变的启动,并减少了亡.
- 鉴定出PTEN-L是一种酸酶,向pSer65-Parkin和pSer65-Ub,抑制了线粒.
结论:
- 子病的发病包括PrP106-126诱导的PTEN-L的上调,这会通过脱Parkins和ubiquitin.
- 在病中,PTEN-L充当了线粒开始的关键调节者.
- 准PTEN-L是一个有前途的治疗策略,用于病.
更多相关视频
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
相关概念视频
Lysosomal Hydrolases
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Parkinson's Disease: Overview
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
